Literature DB >> 2908920

Overexpression of N-ras oncogene and epidermal growth factor receptor gene in human glioblastomas.

M A Gerosa1, D Talarico, C Fognani, E Raimondi, M Colombatti, G Tridente, L De Carli, G Della Valle.   

Abstract

Five human glioblastoma cell lines were analyzed for oncogene activation with a panel of probes. Abnormal expression of the epidermal growth factor receptor (EGFr) gene was detected in four of five lines; N-ras oncogene overexpression was found in all five cell lines. These results were subsequently confirmed with fresh brain tumor and nonneoplastic brain tissue biopsy samples; increased expression of the N-ras proto-oncogene was observed in five of five glioblastomas, all of which also showed EGFr gene overexpression, but not in well-differentiated gliomas or in nonneoplastic brain tissue specimens. No significant differences in Ha-ras and Ki-ras expression were observed. Preliminary histochemical observations showed that intracellular levels of transforming growth factor alpha, a putative biochemical link between these two oncogenes, were significantly higher in glioblastoma cells than in controls.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2908920     DOI: 10.1093/jnci/81.1.63

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  16 in total

Review 1.  Molecular genetics of neurological tumours.

Authors:  R Y Chung; B R Seizinger
Journal:  J Med Genet       Date:  1992-06       Impact factor: 6.318

2.  A 5'-truncated c-myc gene variant not associated with a risk of cancer.

Authors:  N S Pellegata; G Bergamaschi; D Amadori; A Aloia; P Ballarini; L Del Senno; L Amaducci; G N Ranzani
Journal:  Hum Genet       Date:  1991-09       Impact factor: 4.132

3.  Cell density modulates SHC3 expression and survival of human glioblastoma cells through Fak activation.

Authors:  Alberto Azzalin; Elena Moretti; Eloisa Arbustini; Lorenzo Magrassi
Journal:  J Neurooncol       Date:  2014-07-26       Impact factor: 4.130

Review 4.  Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis.

Authors:  Balveen Kaur; Fatima W Khwaja; Eric A Severson; Shannon L Matheny; Daniel J Brat; Erwin G Van Meir
Journal:  Neuro Oncol       Date:  2005-04       Impact factor: 12.300

Review 5.  Experimental approaches for the treatment of malignant gliomas.

Authors:  Leopold Arko; Igor Katsyv; Grace E Park; William Patrick Luan; John K Park
Journal:  Pharmacol Ther       Date:  2010-06-08       Impact factor: 12.310

6.  Inhibition of collagenolytic activity relates to quantitative reduction of invasion in vitro in a c-Ha-ras transfected glial cell line.

Authors:  E R Boghaert; S K Chan; C Zimmer; D Grobelny; R E Galardy; T C Vanaman; S G Zimmer
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

7.  Effects of vitamin D and retinoic acid on human glioblastoma cell lines.

Authors:  L Magrassi; G Butti; S Pezzotta; L Infuso; G Milanesi
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

8.  Targeting HER3 with miR-450b-3p suppresses breast cancer cells proliferation.

Authors:  Zhen Zhao; Rui Li; Sha Sha; Qiong Wang; Weidong Mao; Tao Liu
Journal:  Cancer Biol Ther       Date:  2014-07-21       Impact factor: 4.742

Review 9.  Genetic alterations in glioma and medulloblastoma.

Authors:  B K Rasheed; S H Bigner
Journal:  Cancer Metastasis Rev       Date:  1991-12       Impact factor: 9.264

10.  A cell line of human malignant astrocytoma producing autocrine growth factor.

Authors:  K Arai; Y Horie; M Kurimoto; S Endoh; K Hiraga; A Takaku
Journal:  In Vitro Cell Dev Biol       Date:  1991-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.